Matthias graduated from the University of Vienna in molecular biology. In 2011 he joined Themis Bioscience, a biotech start-up specialized in the development of vaccines against emerging infectious diseases. At Themis he established the Technical Operations Department and led the group for over a decade. In early 2023, Matthias co-founded bespark*bio to continue his passion for developing CMC strategies and manufacturing processes for for novel biotherapeutics